Oncolytic herpesvirus effectively treats murine squamous cell carcinoma and spreads by natural lymphatics to treat sites of lymphatic metastases.
about
Imaging of lymph node micrometastases using an oncolytic herpes virus and [F]FEAU PET.Oncolytic herpes simplex virus vectors and chemotherapy: are combinatorial strategies more effective for cancer?Minimally invasive localization of oncolytic herpes simplex viral therapy of metastatic pleural cancer.Herpes simplex virus based gene therapy enhances the efficacy of mitomycin C for the treatment of human bladder transitional cell carcinoma5-fluorouracil and gemcitabine potentiate the efficacy of oncolytic herpes viral gene therapy in the treatment of pancreatic cancerRadiation therapy potentiates effective oncolytic viral therapy in the treatment of lung cancer.Cisplatin-induced GADD34 upregulation potentiates oncolytic viral therapy in the treatment of malignant pleural mesotheliomaUse of positron emission tomography to target prostate cancer gene therapy by oncolytic herpes simplex virus.Real-time diagnostic imaging of tumors and metastases by use of a replication-competent herpes vector to facilitate minimally invasive oncological surgery.Virally-directed fluorescent imaging (VFI) can facilitate endoscopic staging.Estrogen enhances the efficacy of an oncolytic HSV-1 mutant in the treatment of estrogen receptor-positive breast cancer.Genetic metamorphosis of herpes simplex virus-1 into a biological therapeutic for human cancer.Fluorescence-assisted cytological testing (FACT): Ex Vivo viral method for enhancing detection of rare cancer cells in body fluids.Virally directed fluorescent imaging improves diagnostic sensitivity in the detection of minimal residual disease after potentially curative cytoreductive surgery.Imaging and therapy of malignant pleural mesothelioma using replication-competent herpes simplex viruses.Designing Herpes Viruses as Oncolytics.Oncolytic herpes simplex virus kills stem-like tumor-initiating colon cancer cellsHuman Trial of a Genetically Modified Herpes Simplex Virus for Rapid Detection of Positive Peritoneal Cytology in the Staging of Pancreatic Cancer.Synergy of a herpes oncolytic virus and paclitaxel for anaplastic thyroid cancer.Tunneling nanotubes: an alternate route for propagation of the bystander effect following oncolytic viral infection.Regional liver therapy using oncolytic virus to target hepatic colorectal metastases.Current status and future perspectives of fluorescence-guided surgery for cancer.Role of MAPK in oncolytic herpes viral therapy in triple-negative breast cancer.Epithelial-mesenchymal transition enhances response to oncolytic herpesviral therapy through nectin-1.In vitro detection of cholangiocarcinoma cells using a fluorescent protein-expressing oncolytic herpes virus.Targeting Nucleotide Biosynthesis: A Strategy for Improving the Oncolytic Potential of DNA Viruses.Widespread intratumoral virus distribution with fractionated injection enables local control of large human rhabdomyosarcoma xenografts by oncolytic herpes simplex viruses.Oncolytic virotherapy in upper gastrointestinal tract cancers.
P2860
Q33416415-7133AE4E-810D-47B0-BFF6-5F70D4BCBDA6Q33995471-8E45070E-AC74-4517-8EC9-B01C0B5A36C7Q34313234-5FAC9BDD-09BA-4FF0-A683-E1DDF6714CA7Q34313378-3FD2627C-70EF-4AE1-B87D-990FA5B3AF93Q34374721-1F66C402-14D7-474B-9C05-6AA15C014AA4Q34375025-3570C837-8D38-498C-AB06-13DB1BCE4E16Q34411569-C16EB626-6EEE-4CB4-9692-72D0AF8C62E5Q34441869-23667E9D-0418-4EB6-940B-4FC7934AB11EQ34507179-CD11D332-993B-4329-8694-9372550C9E10Q34536549-5189F846-C01E-4D4F-8473-94119ECE7B86Q34601083-0416DDC8-29A3-4FFE-A17F-C9F6DF79675CQ35116166-C3C6A4C4-5ED9-435D-9F47-19899F0CE68BQ35136699-B056B13B-1FF7-4284-8A80-64320DD81ABAQ35613094-7F6B3645-B42D-46B8-877C-6F20ADEEEFB3Q35649214-F5D7AE27-17C4-410C-84EB-9CCF7E3BECC8Q36142487-498F6D02-07FA-466A-B82E-6C806046BE3FQ37007756-71A2499F-1E03-49E9-82E7-508F7B84D838Q37008504-33ABF048-72EC-4A7E-86D1-730BDCCCC8B2Q37286038-C3DF4707-74F5-46B1-9781-12FA3AD836E4Q37481536-718F1EB3-65C5-480F-B44B-B92B3B659B62Q37759934-C7D6B8B0-5A74-4A89-9314-64C5A0EC100BQ38633227-654BE7F6-F6C1-494C-B380-5481AC18BE0AQ38985441-068ABD1B-C1DC-41F9-9B26-B8E4A407E70DQ39020984-8A138243-6319-48DC-9936-1608F35319ECQ40242582-8C2DCF77-5E4F-43E6-ABB8-64F6A895C607Q41919532-B9832F78-FB2E-47ED-9DCF-178BD5A567F5Q45520731-58374F87-1A1D-4E19-A2AD-8D0AC9496D36Q54242367-E38C8EB7-CDC7-470C-BD11-03A2D542FA42
P2860
Oncolytic herpesvirus effectively treats murine squamous cell carcinoma and spreads by natural lymphatics to treat sites of lymphatic metastases.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Oncolytic herpesvirus effectiv ...... sites of lymphatic metastases.
@en
type
label
Oncolytic herpesvirus effectiv ...... sites of lymphatic metastases.
@en
prefLabel
Oncolytic herpesvirus effectiv ...... sites of lymphatic metastases.
@en
P2093
P1433
P1476
Oncolytic herpesvirus effectiv ...... sites of lymphatic metastases.
@en
P2093
Brian Horsburgh
John K Joe
Richard J Wong
Se-Heon Kim
P304
P356
10.1089/104303402320138998
P577
2002-07-01T00:00:00Z